PeptideDB

2(5H)-Furanone (γ-Crotonolactone) 497-23-4

2(5H)-Furanone (γ-Crotonolactone) 497-23-4

CAS No.: 497-23-4

2(5H)-Furanone is an endogenously produced metabolite.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

2(5H)-Furanone is an endogenously produced metabolite.

Physicochemical Properties


Molecular Formula C4H4O2
Molecular Weight 84.07
Exact Mass 84.021
CAS # 497-23-4
PubChem CID 10341
Appearance Colorless to light yellow liquid
Density 1.2±0.1 g/cm3
Boiling Point 203.7±0.0 °C at 760 mmHg
Melting Point 4-5 °C(lit.)
Flash Point 101.1±0.0 °C
Vapour Pressure 0.3±0.4 mmHg at 25°C
Index of Refraction 1.481
LogP -0.84
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 2
Rotatable Bond Count 0
Heavy Atom Count 6
Complexity 93.7
Defined Atom Stereocenter Count 0
SMILES

O1C(C([H])=C([H])C1([H])[H])=O

InChi Key VIHAEDVKXSOUAT-UHFFFAOYSA-N
InChi Code

InChI=1S/C4H4O2/c5-4-2-1-3-6-4/h1-2H,3H2
Chemical Name

2H-furan-5-one
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Human Endogenous Metabolite
Additional Infomation But-2-en-4-olide is a butenolide. It is a tautomer of a but-3-en-4-olide.
2(5H)-Furanone has been reported in Camellia sinensis, Fusarium graminearum, and other organisms with data available.
See also: Butenolide (annotation moved to).

Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (1189.48 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (29.74 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (29.74 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (29.74 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 11.8948 mL 59.4742 mL 118.9485 mL
5 mM 2.3790 mL 11.8948 mL 23.7897 mL
10 mM 1.1895 mL 5.9474 mL 11.8948 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.